MedTrace Logo

Role of Wireless Monitoring in Internal Medicine Unit for Ongoing Assessment of Acute Instable Patients

NCT03050034 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 296

Last updated 2017-02-10

No results posted yet for this study

Summary

The present study was planned to provide clinical data on the impact of acute and critically ill patients in Internal Medicine Unit activity and economic data enabling to quantify the relative cost of acute patients management during ordinary hospitalization. In these critically ill complex patients the vital parameters continuous monitoring could help in improving the quality of care. Therefore, the study will check how the wireless continuous monitoring in acute selected patients is able to reduce major complications improving the patient's outcome and the quality of care and reducing costs compared to traditional monitoring performed at regular intervals by the nursing staff.

Conditions

  • Wireless Vital Signs Monitoring System
  • Acutely Ill Complex and Poly-pathological Patients
  • Internal Medicine Unit Mission

Interventions

DEVICE

WIN @ Hospital system

WIN @ Hospital system is a wearable and wireless system (Medical Class IIA) that allows continuous and real-time vital signs monitoring, automatically calculating the NEWS score with a personalized alert system for the patient. It does not require the continuous presence of the nurse in front of the control room, but is working with alert on portable devices (ipad).

OTHER

Traditional monitoring

Vital signs control performed by nurse staff each 6 hours or more, according to medical advice.

Sponsors & Collaborators

  • ASST-Garda: Internal Medicina Unit Manerbio Hospital (BS)

    collaborator UNKNOWN

  • University of Modena and Reggio Emilia

    collaborator OTHER

  • Milano-Bicocca University Medical Statistic Department

    collaborator UNKNOWN

  • Azienda Socio Sanitaria Territoriale del Garda

    lead OTHER_GOV

Principal Investigators

  • Filomena Pietrantonio, MD · ASST GARDA

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-27
Primary Completion
2017-10-27
Completion
2018-02-27

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03050034 on ClinicalTrials.gov